Sj. Morland et al., MUTATION OF GALACTOSE-1-PHOSPHATE URIDYL TRANSFERASE AND ITS ASSOCIATION WITH OVARIAN-CANCER AND ENDOMETRIOSIS, International journal of cancer, 77(6), 1998, pp. 825-827
Impaired galactose metabolism has been proposed as a risk factor far o
varian cancer and endometriosis, which is a putative precursor of endo
metrioid and clear cell histological sub-types of ovarian cancer. The
prevalence of the most common galactose-1-phosphate uridyl transferase
gene mutations, Q188R and N314D, was assessed in 206 women with ovari
an cancer, 78 women with endometriosis and 248 controls. No Q188R muta
tions were found in any of the groups. A statistically significant inc
rease in the frequency of N314D mutations was observed in women with s
erous and undifferentiated histological sub-types of ovarian cancer, b
ut not mucinous, endometrioid or clear cell sub-types. There were no s
ignificant differences observed in the N314D mutation frequency betwee
n women with endometriosis (18%) and controls (17%). Our results suppo
rt previous reports of an association of impaired galactose metabolism
with serous and undifferentiated ovarian cancers but contradict previ
ous findings of increased N314D mutation frequencies among women with
endometriosis and endometrioid and clear cell sub-types ovarian cancer
. (C) 1998 Wiley-Liss, Inc.